Veradermics
MANE | NYSE
$139.69
-$4.16 (-2.89%)
At close: Oct 30, 2026, 4:00 PM ET
$141.71
+$2.02 (+1.45%)
Pre-market:
Nov 2, 2026, 7:25 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
Cash & Equivalents | 21.77M | 53.08M | 16.3M |
Short-Term Investments | 120.1M | n/a | n/a |
Long-Term Investments | n/a | 3.85M | 894K |
Other Long-Term Assets | n/a | n/a | -1 |
Receivables | 1.26M | 1.38M | n/a |
Inventory | n/a | n/a | n/a |
Other Current Assets | 3.77M | 38K | 46K |
Total Current Assets | 152.49M | 55.54M | 17.56M |
Property-Plant & Equipment | 125K | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a |
Total Long-Term Assets | 125K | 3.85M | 894K |
Total Assets | 152.62M | 59.38M | 18.46M |
Account Payables | 2.13M | 2.25M | 1.85M |
Deferred Revenue | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a |
Other Current Liabilities | 47K | 1.44M | 436K |
Total Current Liabilities | 9.15M | 4.72M | 3.05M |
Long-Term Debt | n/a | n/a | 786K |
Other Long-Term Liabilities | 264.48M | n/a | n/a |
Total Long-Term Liabilities | 264.48M | n/a | 786K |
Total Liabilities | 273.63M | 4.72M | 3.84M |
Total Debt | 4K | n/a | 786K |
Book Value | -121.01M | 54.67M | 14.62M |
Book Value Per Share | -3.45 | 0.27 | 0.07 |
Common Stock | 1K | 1K | 1K |
Retained Earnings | -123.42M | -49.23M | -22.74M |
Comprehensive Income | 60K | n/a | n/a |
Shareholders Equity | -121.01M | 54.67M | 14.62M |
Total Investments | 120.1M | 3.85M | 894K |
Add to Watchlist
Select watchlists to add or remove MANE